Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 113
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05864742 | Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma | ||
| NCT07527819 | Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC) | ||
| NCT05154162 | PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI | ||
| NCT05878288 | Deep sequencIng in Cutaneous Squamous CEll caRciNomas | ||
| NCT03851146 | A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours | ||
| NCT00581880 | Measuring Hope and Hopelessness in Cancer | ||
| NCT06812715 | Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib | ||
| NCT06082128 | FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers | ||
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT05182931 | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) | ||
| NCT05053854 | PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours | ||
| NCT04641013 | Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) | ||
| NCT05521412 | EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T | ||
| NCT06882499 | Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II | ||
| NCT04914741 | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) | ||
| NCT05184790 | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | ||
| NCT03331731 | A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma | ||
| NCT00418210 | Accelerated Partial Breast Irradiation for Early Breast Cancer | ||
| NCT01755650 | Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies | ||
| NCT03658447 | PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) | ||
| NCT04769817 | ProsTIC Registry of Men Treated With PSMA Theranostics | ||
| NCT04316013 | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial | ||
| NCT00400556 | ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells | ||
| NCT05095519 | Hepatocellular Carcinoma Imaging Using PSMA PET/CT | ||
| NCT04801966 | Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study | ||
| NCT07213076 | Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib. | ||
| NCT00110162 | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | ||
| NCT02662062 | Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer | ||
| NCT04918810 | Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer | ||
| NCT03034577 | Deep Neuromuscular Block for Laparoscopic Surgery | ||
| NCT00351598 | Lung Tumour Volume Database | ||
| NCT05592938 | Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) | ||
| NCT00431990 | A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma | ||
| NCT01676428 | A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases | ||
| NCT03806764 | Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient | ||
| NCT02999893 | A Study of APR-246 in Oesophageal Cancer | ||
| NCT03900884 | Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer | ||
| NCT03980171 | Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma | ||
| NCT05340374 | Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer | ||
| NCT00434239 | Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia | ||
| NCT02506556 | Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer | ||
| NCT07090369 | Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT05263700 | FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary | ||
| NCT07263815 | EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET | ||
| NCT04819607 | The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. | ||
| NCT06631872 | Implementing Surgery School Prehabilitation Using Telehealth | ||
| NCT01658241 | Panobinostat Biological Correlates Study | ||
| NCT00193934 | Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer | ||
| NCT07217938 | Novel Treatment of Radiation Associated Dysphagia With Statins | ||
| NCT04619147 | Invasive Fungal Infections in Patients Following Stem Cell Transplant |
